Report Details
Not found what are you looking for
Medical Care
Global Immuno Oncology Market Research Report 2022(Status and Outlook)
Description
ToC
Tables & Figures
Companies
Speak with Analyst
Report Overview
The global immuno-oncology market size was USD 43698.02 million in 2021 and is expected to register a robust revenue CAGR of 15.05% during the forecast period. Key factors such as rising prevalence of various cancer types, rapid advancements in cancer treatment, and growing adoption of targeted therapy are expected to drive global market growth between 2022 and 2028.
Over years, there has been a rapid increase in the prevalence of various types of cancers including brain tumors, breast cancer, lung cancer, myeloma, cervical cancer, leukemia, and pancreatic cancer among others. Several research and healthcare centers, and pharmaceutical companies are focused on developing advanced technology for treating cancer. One of the trending and widely used cancer treatments is immuno-oncology (IO). IO therapies are novel types of cancer therapies in which an individual’s immune system is used to prevent, control, and eliminate the illness. Immuno-oncology comes in a variety of forms including cancer vaccines, tumor-infecting viruses, targeted antibodies, checkpoint inhibitors, adjuvants, and cytokines. Some immunotherapy treatments help the immune system to slow or halt the growth of cancer cells, while some help to destroy cancer cells and stop them from spreading to other body parts.
Factors such as increasing demand for personalized medicine, improving healthcare infrastructure, rising healthcare spending capacity, favorable government initiatives and support to promote cancer care, and increasing investments for developing novel and innovative drugs for immunotherapy are expected to drive global market growth going ahead.
However, rising product recalls by regulatory authorities such as US FDA, high cost of immuno-oncology treatment and drugs, low consumer awareness, and dearth of skilled healthcare professionals in many developing economies are expected to hamper overall market growth during the forecast period.
Cancer Vaccines Segment To Register Rapid Revenue CAGR:
The cancer vaccines segment is expected to register rapid revenue CAGR over the forecast period owing to increasing prevalence of various cancer types, growing adoption of treatment vaccines, increasing preference for personalized medicine rising number of clinical trials, and ongoing research on cancer vaccines.
Drugstores Segment to Account for Largest Revenue Share:
The drugstores segment is expected to account for largest revenue share during the forecast period owing to growing awareness about immunotherapy, increasing availability of immuno-oncology drugs at several drugstores, and rising number of hospital pharmacies and drugstores worldwide.
North America to Lead In Terms of Revenue Share:
North America is expected to account for largest revenue share during the forecast period owing to increasing prevalence of various types of cancer, presence of well-developed healthcare infrastructure and research facilities, rapid advancements in cancer therapy and drugs, and growing awareness about benefits of immune-oncology therapy. Other factors such as rising spending capacity, rising investments in developing advanced drugs and treatment for immuno-oncology, and presence of robust key players are expected to drive North America market growth between 2022 and 2028.
Global Immuno Oncology Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
•Bristol-Myers Squibb
•Merck and Co., Inc.
•Roche AG
•AstraZeneca, Plc
•Sanofi S.A.
•Dendreon Pharmaceuticals
•Novartis
•Gilead Sciences Inc.
•Merck KGaA
Market Segmentation (by Type)
•Immune Checkpoint Inhibitors
•Cytokine-Based Immunotherapy
•Cancer Vaccines
•CAR-T Cell Therapy
•Others
•Immuno-
Market Segmentation (by Application)
•Hospitals
•Drugstores
•Others
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Immuno-oncology Industry Recent Developments:
In Taconic Biosciences announced the expansion of its premium immune-oncology portfolio with the launch of new immune-oncology mouse model, B2m-NOG mouse model.
In December 2021, Sanofi announced acquisition of Amunix Pharmaceuticals, Inc. a leading immune-oncology company leveraging its proprietary Amunix immune-oncology pipeline with next generation Conditionally Activated Biologics.
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Immuno Oncology Market
• Overview of the regional outlook of the Immuno Oncology Market:
Key Reasons to Purchase:
Estimates 2022 to 2028 immuno-oncology market current market trends and development trends
Market dynamics along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the immuno-oncology market
Competitive landscape involving market share of the major players, new strategies and projects adopted by players in the last five years
Comprehensive company profiles covering product offerings, key financial information, SWOT analysis and strategies employed by major market players
Brief about impact of COVID-19 on the global Immuno-oncology market
Key Questions Addressed:
What revenue CAGR is the global market expected to register during the forecast period?
Which key players are leading in the global immuno-oncology market?
What is the expected market size of the global immuno-oncology market between 2022 and 2028?
What factors are expected to open new growth avenues and opportunities for existing and emerging market players?
What are some of the key challenges that the global market is expected to face during the forecast period?
Which region is expected to account for largest revenue share over the forecast period?
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno Oncology Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
FAQ
- You should buy this report from Xcellent Insights for a better clarity on market scenarios.
- The market report has been prepared using a pragmatic approach to suit your needs.
- We have an extensive library of reports that can help you understand the market landscape and make informed decisions about your business.
- Additionally, the reports are written by experienced analysts who have a deep understanding of the market and the latest trends.
- Besides, customization is a value-added service if you decide to opt.
Table of Content
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immuno Oncology
1.2 Key Market Segments
1.2.1 Immuno Oncology Segment by Type
1.2.2 Immuno Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Immuno Oncology Market Overview
2.1 Global Immuno Oncology Market Size (M USD) Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Immuno Oncology Market Competitive Landscape
3.1 Global Immuno Oncology Revenue Market Share by Manufacturers (2017-2022)
3.2 Immuno Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturers Immuno Oncology Sales Sites, Area Served, Service Type
3.4 Immuno Oncology Market Competitive Situation and Trends
3.4.1 Immuno Oncology Market Concentration Rate
3.4.2 Global 5 and 10 Largest Immuno Oncology Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Immuno Oncology Value Chain Analysis
4.1 Immuno Oncology Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Immuno Oncology Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Immuno Oncology Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno Oncology Market Size Market Share by Type (2017-2022)
6.3 Global Immuno Oncology Sales Growth Rate by Type (2017-2022)
7 Immuno Oncology Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno Oncology Market Size (M USD) by Application (2017-2022)
7.3 Global Immuno Oncology Sales Growth Rate by Application (2017-2022)
8 Immuno Oncology Market Segmentation by Region
8.1 Global Immuno Oncology Market Size by Region
8.1.1 Global Immuno Oncology Market Size by Region
8.1.2 Global Immuno Oncology Market Share by Region
8.2 North America
8.2.1 North America Immuno Oncology Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immuno Oncology Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immuno Oncology Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immuno Oncology Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immuno Oncology Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Immuno Oncology Basic Information
9.1.2 Bristol-Myers Squibb Immuno Oncology Product Overview
9.1.3 Bristol-Myers Squibb Immuno Oncology Product Market Performance
9.1.4 Bristol-Myers Squibb Business Overview
9.1.5 Bristol-Myers Squibb Immuno Oncology SWOT Analysis
9.1.6 Bristol-Myers Squibb Recent Developments
9.2 Merck and Co., Inc.
9.2.1 Merck and Co., Inc. Immuno Oncology Basic Information
9.2.2 Merck and Co., Inc. Immuno Oncology Product Overview
9.2.3 Merck and Co., Inc. Immuno Oncology Product Market Performance
9.2.4 Merck and Co., Inc. Business Overview
9.2.5 Merck and Co., Inc. Immuno Oncology SWOT Analysis
9.2.6 Merck and Co., Inc. Recent Developments
9.3 Roche AG
9.3.1 Roche AG Immuno Oncology Basic Information
9.3.2 Roche AG Immuno Oncology Product Overview
9.3.3 Roche AG Immuno Oncology Product Market Performance
9.3.4 Roche AG Business Overview
9.3.5 Roche AG Immuno Oncology SWOT Analysis
9.3.6 Roche AG Recent Developments
9.4 AstraZeneca, Plc
9.4.1 AstraZeneca, Plc Immuno Oncology Basic Information
9.4.2 AstraZeneca, Plc Immuno Oncology Product Overview
9.4.3 AstraZeneca, Plc Immuno Oncology Product Market Performance
9.4.4 AstraZeneca, Plc Business Overview
9.4.5 AstraZeneca, Plc Immuno Oncology SWOT Analysis
9.4.6 AstraZeneca, Plc Recent Developments
9.5 Sanofi S.A.
9.5.1 Sanofi S.A. Immuno Oncology Basic Information
9.5.2 Sanofi S.A. Immuno Oncology Product Overview
9.5.3 Sanofi S.A. Immuno Oncology Product Market Performance
9.5.4 Sanofi S.A. Business Overview
9.5.5 Sanofi S.A. Immuno Oncology SWOT Analysis
9.5.6 Sanofi S.A. Recent Developments
9.6 Dendreon Pharmaceuticals
9.6.1 Dendreon Pharmaceuticals Immuno Oncology Basic Information
9.6.2 Dendreon Pharmaceuticals Immuno Oncology Product Overview
9.6.3 Dendreon Pharmaceuticals Immuno Oncology Product Market Performance
9.6.4 Dendreon Pharmaceuticals Business Overview
9.6.5 Dendreon Pharmaceuticals Recent Developments
9.7 Novartis
9.7.1 Novartis Immuno Oncology Basic Information
9.7.2 Novartis Immuno Oncology Product Overview
9.7.3 Novartis Immuno Oncology Product Market Performance
9.7.4 Novartis Business Overview
9.7.5 Novartis Recent Developments
9.8 Gilead Sciences Inc.
9.8.1 Gilead Sciences Inc. Immuno Oncology Basic Information
9.8.2 Gilead Sciences Inc. Immuno Oncology Product Overview
9.8.3 Gilead Sciences Inc. Immuno Oncology Product Market Performance
9.8.4 Gilead Sciences Inc. Business Overview
9.8.5 Gilead Sciences Inc. Recent Developments
9.9 Merck KGaA
9.9.1 Merck KGaA Immuno Oncology Basic Information
9.9.2 Merck KGaA Immuno Oncology Product Overview
9.9.3 Merck KGaA Immuno Oncology Product Market Performance
9.9.4 Merck KGaA Business Overview
9.9.5 Merck KGaA Recent Developments
10 Immuno Oncology Regional Market Forecast
10.1 Global Immuno Oncology Market Size Forecast
10.2 Global Immuno Oncology Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Immuno Oncology Market Size Forecast by Country
10.2.3 Asia Pacific Immuno Oncology Market Size Forecast by Region
10.2.4 South America Immuno Oncology Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Immuno Oncology by Country
11 Market Segmentation & Size Forecast (2023-2028)
11.1 Global Immuno Oncology Market Forecast by Type (2023-2028)
11.2 Global Immuno Oncology Market Forecast by Application (2023-2028)
12 Conclusion and Key Findings
Tables and Figures
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immuno Oncology Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Immuno Oncology Revenue (M USD) by Manufacturers (2017-2022)
Table 6. Global Immuno Oncology Revenue Share by Manufacturers (2017-2022)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Oncology as of 2021)
Table 8. Manufacturers Immuno Oncology Sales Sites and Area Served
Table 9. Manufacturers Immuno Oncology Service Type
Table 10. Global Immuno Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Immuno Oncology
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Immuno Oncology Market Challenges
Table 18. Market Restraints
Table 19. Global Immuno Oncology Market Size by Type (M USD)
Table 20. Global Immuno Oncology Market Size (M USD) by Type (2017-2022)
Table 21. Global Immuno Oncology Market Size Share by Type (2017-2022)
Table 22. Global Immuno Oncology Sales Growth Rate by Type (2017-2022)
Table 23. Global Immuno Oncology Sales (K Units) by Application
Table 24. Global Immuno Oncology Market Size by Application
Table 25. Global Immuno Oncology Sales by Application (2017-2022) & (M USD)
Table 26. Global Immuno Oncology Market Share by Application (2017-2022)
Table 27. Global Immuno Oncology Sales Growth Rate by Application (2017-2022)
Table 28. Global Immuno Oncology Market Size by Region (2017-2022) & (M USD)
Table 29. Global Immuno Oncology Market Share by Region (2017-2022)
Table 30. North America Immuno Oncology Market Size by Country (2017-2022) & (M USD)
Table 31. Europe Immuno Oncology Market Size by Country (2017-2022) & (M USD)
Table 32. Asia Pacific Immuno Oncology Market Size by Region (2017-2022) & (M USD)
Table 33. South America Immuno Oncology Market Size by Country (2017-2022) & (M USD)
Table 34. Middle East and Africa Immuno Oncology Market Size by Region (2017-2022) & (M USD)
Table 35. Bristol-Myers Squibb Immuno Oncology Basic Information
Table 36. Bristol-Myers Squibb Immuno Oncology Product Overview
Table 37. Bristol-Myers Squibb Immuno Oncology Revenue (M USD) and Gross Margin (2017-2022)
Table 38. Bristol-Myers Squibb Business Overview
Table 39. Bristol-Myers Squibb Immuno Oncology SWOT Analysis
Table 40. Bristol-Myers Squibb Recent Developments
Table 41. Merck and Co., Inc. Immuno Oncology Basic Information
Table 42. Merck and Co., Inc. Immuno Oncology Product Overview
Table 43. Merck and Co., Inc. Immuno Oncology Revenue (M USD) and Gross Margin (2017-2022)
Table 44. Merck and Co., Inc. Business Overview
Table 45. Merck and Co., Inc. Immuno Oncology SWOT Analysis
Table 46. Merck and Co., Inc. Recent Developments
Table 47. Roche AG Immuno Oncology Basic Information
Table 48. Roche AG Immuno Oncology Product Overview
Table 49. Roche AG Immuno Oncology Revenue (M USD) and Gross Margin (2017-2022)
Table 50. Roche AG Business Overview
Table 51. Roche AG Immuno Oncology SWOT Analysis
Table 52. Roche AG Recent Developments
Table 53. AstraZeneca, Plc Immuno Oncology Basic Information
Table 54. AstraZeneca, Plc Immuno Oncology Product Overview
Table 55. AstraZeneca, Plc Immuno Oncology Revenue (M USD) and Gross Margin (2017-2022)
Table 56. AstraZeneca, Plc Business Overview
Table 57. AstraZeneca, Plc Immuno Oncology SWOT Analysis
Table 58. AstraZeneca, Plc Recent Developments
Table 59. Sanofi S.A. Immuno Oncology Basic Information
Table 60. Sanofi S.A. Immuno Oncology Product Overview
Table 61. Sanofi S.A. Immuno Oncology Revenue (M USD) and Gross Margin (2017-2022)
Table 62. Sanofi S.A. Business Overview
Table 63. Sanofi S.A. Immuno Oncology SWOT Analysis
Table 64. Sanofi S.A. Recent Developments
Table 65. Dendreon Pharmaceuticals Immuno Oncology Basic Information
Table 66. Dendreon Pharmaceuticals Immuno Oncology Product Overview
Table 67. Dendreon Pharmaceuticals Immuno Oncology Revenue (M USD) and Gross Margin (2017-2022)
Table 68. Dendreon Pharmaceuticals Business Overview
Table 69. Dendreon Pharmaceuticals Recent Developments
Table 70. Novartis Immuno Oncology Basic Information
Table 71. Novartis Immuno Oncology Product Overview
Table 72. Novartis Immuno Oncology Revenue (M USD) and Gross Margin (2017-2022)
Table 73. Novartis Business Overview
Table 74. Novartis Recent Developments
Table 75. Gilead Sciences Inc. Immuno Oncology Basic Information
Table 76. Gilead Sciences Inc. Immuno Oncology Product Overview
Table 77. Gilead Sciences Inc. Immuno Oncology Revenue (M USD) and Gross Margin (2017-2022)
Table 78. Gilead Sciences Inc. Business Overview
Table 79. Gilead Sciences Inc. Recent Developments
Table 80. Merck KGaA Immuno Oncology Basic Information
Table 81. Merck KGaA Immuno Oncology Product Overview
Table 82. Merck KGaA Immuno Oncology Revenue (M USD) and Gross Margin (2017-2022)
Table 83. Merck KGaA Business Overview
Table 84. Merck KGaA Recent Developments
Table 85. Global Immuno Oncology Market Size Forecast by Region (M USD)
Table 86. North America Immuno Oncology Market Size Forecast by Country (2023-2028) & (M USD)
Table 87. Europe Immuno Oncology Market Size Forecast by Country (2023-2028) & (M USD)
Table 88. Asia Pacific Immuno Oncology Market Size Forecast by Region (2023-2028) & (M USD)
Table 89. South America Immuno Oncology Market Size Forecast by Country (2023-2028) & (M USD)
Table 90. Middle East and Africa Immuno Oncology Market Size Forecast by Country (2023-2028) & (M USD)
Table 91. Global Immuno Oncology Market Size Forecast by Type (2023-2028) & (M USD)
Table 92. Global Immuno Oncology Market Size Forecast by Application (2023-2028) & (M USD)
LIST OF FIGURES
Figure 1. Industrial Chain of Immuno Oncology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immuno Oncology Market Size (M USD), 2017-2028
Figure 5. Global Immuno Oncology Market Size (M USD) (2017-2028)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Immuno Oncology Market Size (M USD) by Country (M USD)
Figure 10. Global Immuno Oncology Revenue Share by Manufacturers in 2021
Figure 11. Immuno Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 12. The Global 5 and 10 Largest Players: Market Share by Immuno Oncology Revenue in 2021
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Immuno Oncology Market Share by Type
Figure 15. Market Size Share of Immuno Oncology by Type (2017-2022)
Figure 16. Market Size Market Share of Immuno Oncology by Type in 2021
Figure 17. Global Immuno Oncology Sales Growth Rate by Type (2017-2022)
Figure 18. Global Immuno Oncology Market Share by Application
Figure 19. Global Immuno Oncology Market Share by Application (2017-2022)
Figure 20. Global Immuno Oncology Market Share by Application in 2021
Figure 21. Global Immuno Oncology Sales Growth Rate by Application (2017-2022)
Figure 22. Global Immuno Oncology Market Share by Region (2017-2022)
Figure 23. North America Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 24. North America Immuno Oncology Market Share by Country in 2021
Figure 25. U.S. Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 26. Canada Immuno Oncology Market Size (M USD) and Growth Rate (2017-2022)
Figure 27. Mexico Immuno Oncology Market Size (Units) and Growth Rate (2017-2022)
Figure 28. Europe Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 29. Europe Immuno Oncology Market Share by Country in 2021
Figure 30. Germany Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 31. France Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 32. U.K. Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 33. Italy Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 34. Russia Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 35. Asia Pacific Immuno Oncology Market Size and Growth Rate (M USD)
Figure 36. Asia Pacific Immuno Oncology Market Share by Region in 2021
Figure 37. China Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 38. Japan Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 39. South Korea Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 40. India Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 41. Southeast Asia Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 42. South America Immuno Oncology Market Size and Growth Rate (M USD)
Figure 43. South America Immuno Oncology Market Share by Country in 2021
Figure 44. Brazil Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 45. Argentina Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 46. Columbia Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 47. Middle East and Africa Immuno Oncology Market Size and Growth Rate (M USD)
Figure 48. Middle East and Africa Immuno Oncology Market Share by Region in 2021
Figure 49. Saudi Arabia Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 50. UAE Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 51. Egypt Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 52. Nigeria Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 53. South Africa Immuno Oncology Market Size and Growth Rate (2017-2022) & (M USD)
Figure 54. Global Immuno Oncology Market Size Forecast by Value (2017-2028) & (M USD)
Figure 55. Global Immuno Oncology Market Share Forecast by Type (2023-2028)
Figure 56. Global Immuno Oncology Market Share Forecast by Application (2023-2028)
Key Players
•Bristol-Myers Squibb
•Merck and Co., Inc.
•Roche AG
•AstraZeneca, Plc
•Sanofi S.A.
•Dendreon Pharmaceuticals
•Novartis
•Gilead Sciences Inc.
•Merck KGaA
Why Choose Us
- Extensive Library of Reports.
- Identify the clients' needs.
- Pragmatic Research Approach.
- Clarity on Market Scenarios.
- Tailor-Made Solutions.
- Expert Analysts Team.
- Competitive and Fair Prices.
Clientele
Thank you
Xcellent Insights has received your query!